Activation and function of hepatocyte NF-κB in postischemic liver injury

Hepatology

Volumn 42, Issue 1, 2005, Pages 216-218

  Lentsch, Alex B ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AS 602868; I KAPPA B KINASE; I KAPPA B KINASE 1; I KAPPA B KINASE 2; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN ESSENTIAL MODULATOR; UNCLASSIFIED DRUG;

APOPTOSIS; EMBRYO DEATH; EMBRYO DEVELOPMENT; HEMORRHAGIC SHOCK; HEPATITIS; KNOCKOUT MOUSE; LIVER CELL; LIVER INJURY; LIVER ISCHEMIA; LIVER NECROSIS; LIVER PROTECTION; LIVER RESECTION; LIVER TRANSPLANTATION; MOUSE; NONHUMAN; NOTE; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 21344464908     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20779     Document Type: Note

References (16)

1. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003;284: G15-G26.
2. Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. HEPATOLOGY 2000;32:169-173.
3. Zwacka RM, Zhang Y, Zhou W, Halldorson J, Engelhardt JF. Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor κB independently of IκB degradation. HEPATOLOGY 1998;28:1022-1030.
4. Hayden MS, Ghosh S. Signaling to NF-κB. Genes Devel 2004;8:2195-2224.
5. Imbert V, Rupee RA, Livolsi A, Pahl HL, Traenckner EB, Mueller-Dieckmann C, et al. Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α. Cell 1996;86:787-798.
6. Singh S, Darnay BG, Aggarwal BB. Site-specific tyrosine phosphorylation of IκBα negatively regulates its inducible phosphorylation and degradation. J Biol Chem 1996;271:31049-31054.
7. Fan C, Li Q, Ross D, Engelhardt JF. Tyrosine phosphorylation of IκBα activates NFκB through a redox-regulated and c-Src-dependent mechanism following hypoxia/reoxygenation. J Biol Chem 2003;278:2072-2080.
8. Liu H, Lo CR, Czaja MJ. NF-κB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun. HEPATOLOGY 2002;35:772-778.
9. Chaisson ML, Brooling JT, Ladiges W, Tsai S, Fausto N. Hepatocyte-specific inhibition of NF-κB leads to apoptosis after TNF treatment, but not after partial hepatectomy. J Clin Invest 2002;110:193-202.
10. Luedde T, Assmus U, Wustefeld T, Meyer zu Vilsendorf A, Roskams T, Schmidt-Supprian M, et al. Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. J Clin Invest 2005;115:849-859.
11. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 1999;284: 321-325.
12. Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, et al. The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor κB activation and prevention of apoptosis. J Exp Med 1999;189:1839-1845.
13. Tanaka M, Fuentes ME, Yamaguchi K, Durnin MH, Dalrymple SA, Hardy KL, et al. Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice. Immunity 1999;10:421-429.
14. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA Jr. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990;85:1936-1943.
15. Shiratori Y, Hikiba Y, Mawet E, Niwa Y, Matsumura M, Kato N, et al. Modulation of KC/gro protein (interleukin-8 related protein in rodents) release from hepatocytes by biologically active mediators. Biochem Biophys Res Commun 1994;203:1398-1403.
16. Okaya T, Lentsch AB. Hepatic expression of S32A/S36A IκBα does not reduce postischemic liver injury. J Surg Res 2005;124:244-249.